Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-14

Clinical Trial Update: Effectiveness of Inactive Vitamin D Supplementation in Non-Alcoholic Fatty Liver Disease Patients [Phase 3]

View source ↗

Summary

Phase 3 trial assessing inactive vitamin D supplementation for effectiveness in non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • inactive vitamin D supplementation

Snippet

Sponsor: Ain Shams University | Conditions: Non-Alcoholic Fatty Liver Disease | Phase 3 | Status: UNKNOWN